Dayondon, Jane Mae L.

HRN: 27-50-89  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/22/2025
CEFUROXIME 500MG (TAB)
07/22/2025
07/28/2025
PO
500mg
BID X 7 Days
Thinly MSAF
Checking Initial Appropriateness 

 Indication:  Prophylaxis    Type of Infection:  Reproductive Tract    Compliance to guidelines: Compliant To Guidelines